# Open Orphan Human Challenge Programme editorial in New England Journal of Medicine

- Link: https://www.directorstalkinterviews.com/open-orphan-human-challenge-programme-editorial-in-new-england-journal-of-medicine/4121011128
- Published: 2021-07-22T07:46:33+01:00
- Author: Giles

**Open Orphan plc** ([LON:ORPH](https://www.directorstalkinterviews.com/company/open-orphan-plc/orph.l)),
a rapidly growing specialist clinical research organisation (CRO) and a world leader
in vaccine and antiviral testing using human challenge clinical trials, has confirmed
that an editorial opinion piece regarding the UK Government’s Human Challenge Programme
has been published in the latest edition of the New England Journal of Medicine (
NEJM).

The piece, titled _‘Establishing the Model during an Evolving Pandemic’_, explores
the extensive preliminary review process which was commissioned by the UK Government
and delivered by the coalition involved in the COVID-19 Human Challenge Programme
to justify the research and manage and minimise the risks associated with the trial,
as well as arguments supporting the inclusion of a SARS-CoV-2 human challenge research
program as part of the pandemic response.

The Human Challenge Programme, part of the UK Government’s Vaccine Taskforce, is
a collaboration between the UK Government, the Royal Free London NHS Foundation 
Trust, Imperial College London and hVIVO, a subsidiary of Open Orphan, to deliver
the world’s first human challenge study for COVID-19.

In human challenge studies, a small number of healthy volunteers in a controlled
setting are exposed to an infectious agent, in this instance, COVID-19, for scientists
and clinicians to assess how effective vaccines or treatments are against the disease
and identify any side effects.

The NEJM is recognised as the world’s leading medical journal and website. Published
continuously for over 200 years, the NEJM delivers high-quality, peer-reviewed research
and interactive clinical content to physicians, educators, researchers, and the 
global medical community. The publication’s mission is to publish the best research
and information at the intersection of biomedical science and clinical practice 
and to present this information in understandable, clinically useful formats that
inform health care practice and improve patient outcomes.

> **Cathal Friel, Executive Chairman of Open Orphan plc, commented: **_“We are delighted
> to see support for the COVID-19 Human Challenge Programme in a publication such
> as the New England Journal of Medicine. The piece articulates the considerable
> review process commissioned by the UK Government and delivered by hVIVO, in collaboration
> with the Royal Free London NHS Foundation Trust_, _and Imperial College London.
> We believe the UK Government’s COVID-19 Human Challenge Programme will play a 
> vital role in trialling the vaccines and antivirals which continue support our
> effective pandemic response in the UK and abroad.”_

Share on:
